Replies to Post #3693 onLigand Pharmaceuticals Inc (LGND)

Replies to post #3693 on Ligand Pharmaceuticals Inc (LGND)

Replies to #3693 on Ligand Pharmaceuticals Inc (LGND)

05/26/22 4:04 AM

#3694 RE: Stowe #3693

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Ligand Pharma ($LGND – Research Report) today and set a price target of $310.00.

05/26/22 4:07 AM

#3695 RE: Stowe #3693

CEO + President & COO both acquired shares per last 2 announcements. $LGND